HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characterization of modification enzyme NukM and engineering of a novel thioether bridge in lantibiotic nukacin ISK-1.

Abstract
The lantibiotic nukacin ISK-1 is an antimicrobial peptide containing unusual amino acids such as lanthionine and dehydrobutyrine. The nukacin ISK-1 prepeptide (NukA) undergoes posttranslational modifications, such as the dehydration and cyclization reactions required to form the unusual amino acids by the modification enzyme NukM. We have previously constructed a system for the introduction of unusual amino acids into NukA by coexpression of NukM in Escherichia coli. Using this system, we describe the substrate specificity of NukM by the coexpression of a series of NukA mutants. Our results revealed the following characteristics of NukM: (1) its dehydration activity is not coupled to its cyclization activity; (2) its dehydration activity is site-specific; (3) the length of the substrate is important for its dehydration activity. Furthermore, we succeeded in introducing a novel thioether bridge in NukA by replacing an unmodified Ser at position 27 with a Cys residue.
AuthorsKouki Shioya, Yoshitaka Harada, Jun-ichi Nagao, Jiro Nakayama, Kenji Sonomoto
JournalApplied microbiology and biotechnology (Appl Microbiol Biotechnol) Vol. 86 Issue 3 Pg. 891-9 (Apr 2010) ISSN: 1432-0614 [Electronic] Germany
PMID19915831 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Bacteriocins
  • Escherichia coli Proteins
  • nukacin ISK-1
  • Hydro-Lyases
  • NukM protein, E coli
Topics
  • Amino Acid Sequence
  • Bacteriocins (metabolism)
  • Escherichia coli (enzymology, genetics)
  • Escherichia coli Proteins (genetics, metabolism)
  • Hydro-Lyases (genetics, metabolism)
  • Molecular Sequence Data
  • Substrate Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: